APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,256,000 | -6.5% | 1,400,000 | +124.0% | 7.10% | -8.3% |
| Q2 2023 | $56,937,500 | +7.9% | 625,000 | -21.9% | 7.74% | +2.5% |
| Q1 2023 | $52,768,000 | -24.4% | 800,000 | -40.7% | 7.55% | -7.7% |
| Q4 2022 | $69,808,500 | -21.4% | 1,350,000 | +3.8% | 8.18% | -25.1% |
| Q3 2022 | $88,790,000 | +30.9% | 1,300,000 | -13.3% | 10.92% | -12.3% |
| Q2 2022 | $67,830,000 | +48.3% | 1,500,000 | +66.7% | 12.44% | +109.9% |
| Q1 2022 | $45,729,000 | -3.3% | 900,000 | -10.0% | 5.93% | +21.6% |
| Q4 2021 | $47,280,000 | -1.1% | 1,000,000 | -31.0% | 4.88% | +41.5% |
| Q3 2021 | $47,792,000 | +116.1% | 1,450,000 | +314.3% | 3.45% | +85.4% |
| Q2 2021 | $22,120,000 | +28.9% | 350,000 | +16.7% | 1.86% | +26.4% |
| Q4 2020 | $17,160,000 | -4.5% | 300,000 | -48.9% | 1.47% | -66.8% |
| Q4 2019 | $17,977,000 | – | 587,108 | – | 4.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |